![Peter Sandor](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Peter Sandor is currently VP & Head-Oncology Therapeutic Area in Mktg Strat at Astellas Pharma US, Inc. Formerly, Mr. Sandor was VP & Head-Oncology Therapeutic Area in Mktg Strat at Astellas Pharma, Inc. and Chief Strategy Officer at Astellas Pharma, Inc. in 2026.
| Empresas | Cargo | Inicio |
|---|---|---|
Astellas Pharma US, Inc.
 Astellas Pharma US, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | - |
| Empresas | Cargo | Fin |
|---|---|---|
| ASTELLAS PHARMA INC. | Corporate Officer/Principal | 01/07/2026 |
| ASTELLAS PHARMA INC. | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 2 |
|---|---|
Astellas Pharma, Inc.
 Astellas Pharma, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceuticals and related medical products | Health Technology |
Astellas Pharma US, Inc.
Astellas Pharma US, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
